The treatment of Benign Paroxysmal Positional Vertigo & Segmental Pattern Vitiligo with vitamins

Benign Paroxysmal Positional Vertigo and Segmental Pattern Vitiligo: Mitamins custom make quality formulas for the treatment of Benign Paroxysmal Positional Vertigo & Segmental Pattern Vitiligo with vitamins. A Benign Paroxysmal Positional Vertigo & Segmental Pattern Vitiligo formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Benign Paroxysmal Positional Vertigo and Segmental Pattern Vitiligo

  • Amount Per Serving
    % DV
    Vitamin C
    500
    mg
    833%
    Vitamin E
    400
    IU
    1333%
    Thiamin
    100
    mg
    6667%
    Riboflavin
    100
    mg
    5882%
    Niacin
    100
    mg
    500%
    Vitamin B6
    100
    mg
    5000%
    Folate
    400
    mcg
    100%
    Vitamin B12
    100
    mcg
    1667%
  • Amount Per Serving
    % DV
    Biotin
    100
    mcg
    33%
    Pantothenic Acid
    100
    mg
    1000%
    Choline Bitartrate
    100
    mg
    *
    Inositol
    100
    mg
    *
    PABA
    100
    mg
    *
    Ginkgo Extract
    120
    mg
    *
    DL-Phenylalanine
    750
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Benign Paroxysmal Positional Vertigo and Segmental Pattern Vitiligo
Serving Size:4-5

Benign Paroxysmal Positional Vertigo and Segmental Pattern Vitiligo Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Argenes Initiates Phase I Clinical Study Of ARG098 (Anti-Fas IgM Monoclonal Antibody), A Novel Therapeutics For Rheumatoid Arthritis, In Europe
Tokyo, Japan - Argenes, Inc. announce that it has started Phase I clinical study of the novel anti-rheumatoid arthritis (RA) agent ARG098 in patients with RA in Belgium and has administered to the first patient. The clinical study intends to evaluate the safety and tolerability of ARG098 into the knee joint cavity of patients with RA and examine its efficacy and pharmacokinetics.Efficacy of ARG098 on RA was found in the collaborative study with Santen Pharmaceutical Co., Ltd.
Sandia And FDA Ensure A Safer Food Supply
Like Johnny Appleseed of yore, the Food and Drug Administration is scattering food-defense programs across the US so that the country's million or so food processors can better secure their food against possible contamination by terrorists.A team from Sandia National Laboratories led the effort to computerize the FDA program so that it will be distributed as widely as possible.Sandia is a National Nuclear Security Administration laboratory.
This information concerning the support of Benign Paroxysmal Positional Vertigo and Segmental Pattern Vitiligo treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments